Sirolimus-Eluting Stents for Treatment of In-Stent Restenosis: Immediate and Late Results
AUTOR(ES)
Medina, Alfonso
RESUMO
We analyzed the clinical, angiographic, and late intravascular ultrasonographic findings from 140 patients whose in-stent restenosis was treated with sirolimus-eluting stents. In-stent restenosis remains the main limitation to percutaneous coronary revascularization and has a high recurrence rate after bare stent implantation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=555815Documentos Relacionados
- Economic evaluation of sirolimus-eluting stents
- Target lesion revascularisation in patients treated with a sirolimus‐eluting or paclitaxel‐eluting stent
- Parallel stenting using two sirolimus‐eluting stents in an ectatic coronary artery stenosis
- Strut fracture of a sirolimus‐eluting stent at the ostium of the right coronary artery
- Intracoronary brachytherapy in the treatment of in-stent restenosis. Initial experience in Brazil
